[{"id":"202b854a-4f0b-4a92-acf1-e16644170e0d","acronym":"","url":"https://clinicaltrials.gov/study/NCT05805371","created_at":"2023-04-10T14:03:01.614Z","updated_at":"2024-07-02T16:35:06.475Z","phase":"Phase 1","brief_title":"PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer","source_id_and_acronym":"NCT05805371","lead_sponsor":"City of Hope Medical Center","biomarkers":" PSCA","pipe":" | ","alterations":" PSCA Expression","tags":["PSCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PSCA Expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MB-105"],"overall_status":"Recruiting","enrollment":" Enrollment 21","initiation":"Initiation: 06/12/2024","start_date":" 06/12/2024","primary_txt":" Primary completion: 08/01/2027","primary_completion_date":" 08/01/2027","study_txt":" Completion: 07/01/2028","study_completion_date":" 07/01/2028","last_update_posted":"2024-05-02"},{"id":"0328902b-7f12-44fb-b4da-f0c7f9276495","acronym":"","url":"https://clinicaltrials.gov/study/NCT03873805","created_at":"2021-03-10T17:53:52.637Z","updated_at":"2024-07-02T16:35:07.197Z","phase":"Phase 1","brief_title":"PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer","source_id_and_acronym":"NCT03873805","lead_sponsor":"City of Hope Medical Center","biomarkers":" PSCA","pipe":" | ","alterations":" PSCA Expression","tags":["PSCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PSCA Expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • MB-105"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 14","initiation":"Initiation: 08/20/2019","start_date":" 08/20/2019","primary_txt":" Primary completion: 08/20/2022","primary_completion_date":" 08/20/2022","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-04-29"}]